Cergentis
1 known investors
Find your way into Cergentis
Cergentis is now part of Solvias and provides Targeted Locus Amplification (TLA) technology and genetic characterization services for advanced therapy development. The company serves pharmaceutical and biotech innovators with CMC analytical testing from drug development through commercialization.
Investors · 1
Frequently asked questions
- What does Cergentis do?
- Cergentis is now part of Solvias and provides Targeted Locus Amplification (TLA) technology and genetic characterization services for advanced therapy development. The company serves pharmaceutical and biotech innovators with CMC analytical testing from drug development through commercialization.
- Who are Cergentis's investors?
- Cergentis's investors include Novalis Biotech.